XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Changes in Stockholders’ Equity (unaudited) - USD ($)
Common Stock
Additional Paid–In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2020 $ 22,181 $ 32,923,022 $ (30,879,031) $ 2,066,172
Balance (in Shares) at Sep. 30, 2020 7,393,637      
Issuance of common stock upon conversion of convertible notes $ 878 1,004,354 1,005,232
Issuance of common stock upon conversion of convertible notes (in Shares) 292,754      
Issuance costs in connection with private placement 50,400 50,400
Stock-based compensation 245,829 245,829
Issuance of common stock upon vesting of restricted stock units $ 31 (31)  
Issuance of common stock upon vesting of restricted stock units (in Shares) 10,450      
Net loss (1,959,480) (1,959,480)
Balance at Dec. 31, 2020 $ 23,090 34,223,574 (32,838,511) 1,408,153
Balance (in Shares) at Dec. 31, 2020 7,696,841      
Issuance of common stock in connection with private placement $ 12,500 8,816,736   8,829,236
Issuance of common stock in connection with private placement (in Shares) 4,166,682      
Issuance of warrants in connection with private placement   3,670,764   3,670,764
Issuance costs in connection with private placement (1,198,080) (1,198,080)
Stock-based compensation   326,359   326,359
Exercise of warrants $ 120 212,379   212,499
Exercise of warrants (in Shares) 39,905      
Exercise of stock options $ 2 4,996   4,998
Exercise of stock options (in Shares) 758      
Issuance of common stock upon vesting of restricted stock units $ 18 (18)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 6,131      
Net loss     (2,393,916) (2,393,916)
Balance at Mar. 31, 2021 $ 35,730 46,056,710 (35,232,427) 10,860,013
Balance (in Shares) at Mar. 31, 2021 11,910,317      
Balance at Sep. 30, 2021 $ 35,834 47,345,266 (40,827,199) 6,553,901
Balance (in Shares) at Sep. 30, 2021 12,010,019      
Issuance of common stock in connection with public offering $ 4,172 13,346,410   13,350,582
Issuance of common stock in connection with public offering (in Shares) 4,172,057      
Issuance cost in connection with public offering   (1,352,280)   (1,352,280)
Stock-based compensation 203,072 203,072
Issuance of common stock upon vesting of restricted stock units $ 6 (6)
Issuance of common stock upon vesting of restricted stock units (in Shares) 5,646      
Net loss (2,807,475) (2,807,475)
Balance at Dec. 31, 2021 $ 40,012 59,542,462 (43,634,674) 15,947,800
Balance (in Shares) at Dec. 31, 2021 16,187,722      
Stock-based compensation   232,716   232,716
Issuance of common stock upon vesting of restricted stock units $ 3 (3)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 3,447      
Net loss     (3,058,067) (3,058,067)
Balance at Mar. 31, 2022 $ 40,015 $ 59,775,175 $ (46,692,741) $ 13,122,449
Balance (in Shares) at Mar. 31, 2022 16,191,169